Skip to main content
Equibles

RAYMOND JAMES FINANCIAL INC

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 720005 ST. PETERSBURG, FL
Back to TEVA Full portfolio

Position in TEVA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$57,347,317
+$2,627,864 QoQ
Shares Held
1,692,660
-6.8% QoQ
Ownership
0.145%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
7 quarters on record
Voting authority Sole 32% Shared 0% None 68%

Common Shares in TEVA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

RAYMOND JAMES FINANCIAL INC holds $626,262,758 across 34 Drug Manufacturers - Specialty & Generic names. TEVA ranks #5 (9.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 1,741,371 $125,134,918
2 NBIX
Neurocrine Biosciences Inc
 580,170 $97,781,849
3 HLN
Haleon plc
 7,278,875 $67,911,902
4 ELAN
Elanco Animal Health Inc
 2,383,479 $58,657,416
5 TEVA
Teva Pharmaceutical Industries Ltd
This page 		1,692,660 $57,347,317
6 UTHR
UNITED THERAPEUTICS Corp
 55,173 $29,894,385
7 VTRS
Viatris Inc
 1,668,730 $26,499,430
8 LNTH
Lantheus Holdings, Inc.
 234,788 $26,047,378

All Filings in TEVA

Export CSV
7 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $57,347,317 1,692,660
2026-03-31 $54,719,453 1,816,715
2025-12-31 $61,770,891 1,979,202
2025-09-30 $33,208,050 1,643,963
2025-06-30 $24,890,007 1,485,084
2025-03-31 $24,870,302 1,618,107
2024-12-31 $38,913,668 1,765,593